Skip to content
Contact us

Experience
AI-Powered Pathology

Demo PathAI's digital pathology solutions for translational research and clinical development 

  • Analyze routine pathology images such as H&E and IHC with single-cell, spatial resolution
  • Extract standardized and structured histopathology features to enable pathology research at scale
  • Visualize disease heterogeneity, cell populations, and tissue architectures with high-resolution AI-powered overlays 
Real-World Data One Pager
PathExploreTM

Introducing PathExplore™ Fibrosis

Unlock the fibrotic microenvironment directly from H&E whole slide images

Learn more about our latest AI-powered tool for characterization of fibrosis, collagen, and fiber for scalable analysis of the tumor microenvironment.  

Learn More

See for yourself: Quantitative pathology in high-resolution

Ready to enhance your pathology data with AI? Register for a demo account to get a closer look into PathAI's products:

Oncology 

  • PathExplore™: Spatially-resolved, single cell analysis from H&E
  • PathExplore™ IOP: Immune Phenotyping & TIL Characterization
  • IHC Explore™: AI-powered biomarker quantification
  • NEW PathExplore™ Fibrosis: Unlock the fibrotic microenvironment directly from H&E whole slide images.

IBD, Liver & MASH

  • IBD Explore™: Spatial, single cell-resolution of the inflammatory microenvironment
  • Liver Explore™: Characterizes liver tissue biopsy microarchitecture
Access the Demo

Work with PathAI across the drug development lifecycle

Offerings Overview (3)
Our mission is to improve patient outcomes with AI-powered pathology

PathAI has developed a comprehensive, scalable precision pathology solution for all stages of drug development. We bring together intelligent software platforms with robust AI algorithms leveraging data from our network of >550 US board-certified pathologists and library of millions of annotations and whole slide images. 

Offerings Overview-2
Offerings Overview (2)-3
Offerings Overview (1)

Our content library

CASE STUDY

AI-Assisted Titer Selection in Early Assay Development

  • PathAI deployed IHC Explore on prostate cancer specimens stained with a novel, in-development assay
  • IHC Explore quantifies staining intensity at single-cell resolution, enabling rapid assay characterization and titer optimization​
  • Continuous staining intensity measurement provides added value for next-generation biomarkers and precision medicine strategies

Oncology

1-4

Oncology

2-3

Oncology

3-3

Oncology

4-2

MASH & Liver

3-4

MASH & Liver

1-Aug-13-2024-06-09-57-1348-PM

MASH & Liver

Content Icons (1)

MASH & Liver

1-Aug-19-2024-05-07-48-3314-PM

IBD

7-1

IBD

6-1

IBD

5-1

Publication Collections

4-3
2-Aug-19-2024-04-55-00-7858-PM
3-Aug-19-2024-04-55-00-7879-PM

PathExplore™ , PathExplore™ IOP, IHC Explore™, Liver Explore™, PathExplore™ Fibrosis, and IBD Explore™ are for research use only. Not for use in diagnostic procedures.